Even if you, you mope, die

Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers - The New York Times

"But Mr. Pearson, a former McKinsey & Company consultant, has said he has a duty to shareholders to wring the maximum profit out of each drug. "